SMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and smoking is a known cause of heart disease, lung cancer, respiratory infections and many other diseases. This has created a large market for smoking cessation aids. The market, which Zyban […]
April 1, 2007
There is an important development occuring in the dental implant industry; one that opens up the procedure to new patients and provides new revenue opportunities. Dental implant systems are fast becoming the preferred restoration for replacement of missing or extracted teeth or as as supports for dentures, crowns and bridges. But poor bone quality eliminated […]
April 1, 2007
New biological treatments are being developed at a record pace, but their potential could be compromised by a significant obstacle: the delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. Kalorama’s Drug Delivery Markets Series covers these new systems. The fourth volume of this series, Kalorama’s Drug Delivery […]
April 1, 2007
The market for antibiotics has changed and a knowledge of the current drug resistance situation is critical before operating in this marketplace. The effectiveness of many antibacterials (antibiotics) is being reduced as more and more types of bacteria become resistant to them. These and other developments are covered in Kalorama’s Anti-Infectives, World Markets, Vol. II: […]
April 1, 2007
Since the advent of LASIK nearly two decades ago, refractive vision correction remains a vibrant market impacted by technology. Kalorama’s market analysis takes a look at the entire market for non-disease eye treatment procedures. Complete coverage of the vision correction market, including the correction of conditions such as myopia (nearsightedness), presbyobia (an inibility to focus), […]
March 1, 2007
The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug delivery market reached $25.5 billion in […]
March 1, 2007